EPCAM and cancer: Previous studies using E-cadherin, EpCAM, and vimentin as tumor markers, have shown that epithelial differentiation of tumors is associated with improved prognosis in many cancer types including breast, ovarian, colorectal, prostate, and gastrointestinal [21], presumably due to the less invasive nature of these tumors.